CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. (Q40455557)
Jump to navigation
Jump to search
scientific article published on March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. |
scientific article published on March 2005 |
Statements
1 reference
CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. (English)
1 reference
Anirban Maitra
1 reference
Donna E Hansel
1 reference
Surajit Dhara
1 reference
RuChih C Huang
1 reference
Raheela Ashfaq
1 reference
Mari Deasel
1 reference
Yutaka Shimada
1 reference
Harold S Bernstein
1 reference
John Harmon
1 reference
Malcolm Brock
1 reference
Arlene Forastiere
1 reference
M Kay Washington
1 reference
Elizabeth Montgomery
1 reference
1 March 2005
1 reference
1 reference
Identifiers
1 reference